What is your approach to using beta-blockers in patients with acute myocardial infarction with preserved LV ejection fraction who undergo early coronary angiography in light of the REDUCE-AMI trial findings?

Topics: Cardiology • Interventional Cardiology

REDUCE-AMI trial

Answer from: at Community Practice

I would not change practice based on the findings of this study alone. Treatment cross-over in both arms of the study may obscure the potential benefits of post-MI beta-blocker therapy in patients with preserved EF.

Comments

at South Carolina Cardiology Consultants
Shared decision-making. Would explain benefits to ...

Related Questions